Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, April 19 2014 8:01am ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Thursday, Apr 17, 2014
·Columbia Laboratories to Discuss First Quarter 2014 Financial Results on April 29th Conference Call
PR Newswire - Thu Apr 17
·Flamel Technologies SA (FLML) Soars: Stock Up 6.6% - Thu Apr 17
Tuesday, Apr 15, 2014
·Is This the Time to Buy Pharma Stocks?
at Motley Fool - Tue Apr 15
·Results from Non-Tuberculous Mycobacteria (NTM) Study Using Aradigm’s Liposomal Ciprofloxacin to be Presented at the American Thoracic Society 2014 International Conference
Business Wire - Tue Apr 15
·Molecular Profiles Strengthens US Presence To Drive Growth
PR Newswire - Tue Apr 15
Monday, Apr 14, 2014
·pSivida Announces September 26, 2014 PDUFA Date for ILUVIEN®
Business Wire - Mon Apr 14
·Intellipharmaceutics Announces First Quarter 2014 Results
GlobeNewswire - Mon Apr 14
Friday, Apr 11, 2014
·Acura Pharmaceuticals' CEO Presents at Return of Product Rights Conference (Transcript)
- Fri Apr 11
Thursday, Apr 10, 2014
·Delcath (DCTH) Enters Oversold Territory - Thu Apr 10
·Acura Pharmaceuticals Announces Return of Product Rights
Marketwire - Thu Apr 10
Tuesday, Apr 8, 2014
·Alkermes to seek schizophrenia drug approval after trial success
Reuters - Tue Apr 8
·Why Alkermes PLC Shares Temporarily Spiked Higher
at Motley Fool - Tue Apr 8
·Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug
at Motley Fool - Tue Apr 8
·Zogenix Wins U.S. Approval for Pure Hydrocodone Pain Pill
at Bloomberg - Tue Apr 8
·Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3
at Investor's Business Daily, Inc. - Tue Apr 8
·Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq
at Seeking Alpha - Tue Apr 8
·UPDATE 1-Alkermes' schizophrenia drug meets main goal of late-stage study
Reuters - Tue Apr 8
·Ahead of the Bell: Alkermes shares jump
AP - Tue Apr 8
·Alkermes Will Seek U.S. Approval for Once-Monthly Schizophrenia Treatment
at - Tue Apr 8
·Alkermes' schizophrenia drug meets main goal of late-stage study
Reuters - Tue Apr 8
More Latest News...
Sponsor Results
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
3DOF Orientation Tracker
Small accurate IMU for 3D measurement of human body segments and more.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?